Andrew G Cole

USPTO Granted Patents = 5 (Patent Applications = 11)

CIPO Patents = 2 (Patent Applications = 14)

EPO Patents = 5 (Patent Applications = 18)

Average Co-Inventor Count = 3.2

ph-index = 1

Company Filing History:

3 out of 57

Arbutus Biopharma Corporation

patents

2 out of 8

Venenum Biodesign, LLC

patents

Years Active: 2020-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11566002 - Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same (2023-01-31),

2. 11236055 - Non-systemic TGR5 agonists (2022-02-01),

3. 11098010 - Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same (2021-08-24),

4. 11001564 - Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same (2021-05-11),

5. 10669242 - toxin inhibitors (2020-06-02),

Title: The Inventor Andrew G Cole

Introduction: Andrew G Cole is a renowned inventor based in Cranbury, New Jersey. He is known for his groundbreaking innovations in various fields.

Latest Patents: Andrew G Cole holds several patents in the areas of technology, healthcare, and consumer products. His most recent patents focus on improving efficiency in renewable energy systems.

Career Highlights: Throughout his career, Andrew G Cole has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His inventions have significantly impacted industries such as telecommunications and sustainable energy.

Collaborations: Andrew G Cole has collaborated with leading research institutions and universities to further develop his inventions. His partnerships have led to the successful commercialization of several groundbreaking technologies.

Conclusion: Andrew G Cole's passion for innovation and dedication to creating a positive impact on society through his inventions make him a standout figure in the world of inventors. His contributions continue to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.